nolvadex-d tablet 20 mg
astrazeneca singapore pte ltd - tamoxifen citrate 30.4mg eqv tamoxifen - tablet, film coated - 20 mg - tamoxifen citrate 30.4mg eqv tamoxifen 20 mg
tenormin tablet 100mg
astrazeneca sdn. bhd. - atenolol -
astrazeneca fentanyl 500 microgram/10ml (as citrate) injection ampoule
juno pharmaceuticals pty ltd - fentanyl citrate, quantity: 78.6 microgram/ml (equivalent: fentanyl, qty 50 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; citric acid; sodium citrate dihydrate; sodium hydroxide - indications as at 31 july 2003: short duration analgesia during pre-medication, induction and maintenance of anaesthesia, and in the immediate post operative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic pre medication for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.
astrazeneca fentanyl 100 microgram/2ml (as citrate) injection ampoule
juno pharmaceuticals pty ltd - fentanyl citrate, quantity: 78.6 microgram/ml (equivalent: fentanyl, qty 50 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid - indications as at 31 july 2003: short duration analgesia during pre-medication, induction and maintenance of anaesthesia, and in the immediate post operative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic pre medication for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.
astrazeneca potassium chloride 750mg/10ml injection ampoule
juno pharmaceuticals pty ltd - potassium chloride -
astrazeneca suxamethonium chloride 100mg/2ml injection bp ampoule
juno pharmaceuticals pty ltd - suxamethonium chloride -
astrazeneca sodium chloride 20% 2g/10ml injection bp ampoule
juno pharmaceuticals pty ltd - sodium chloride, quantity: 200 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indications as at 19 february 1993 : as an additive to parenteral fluids in patients who have specific electrolyte needs. as a sclerosing agent for small symptomatic varicose veins.
astrazeneca neostigmine methylsulfate 2.5mg/1ml injection ampoule
juno pharmaceuticals pty ltd - neostigmine methylsulfate -
astrazeneca pancuronium bromide 4mg/2ml injection bp ampoule
juno pharmaceuticals pty ltd - pancuronium bromide, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; acetic acid; sodium hydroxide - indiactions as at 1 january 1991: 1. as an adjunct to surgical anaesthesia to induce skeletal muscle relaxation to facilitate operative manipulations. the necessary conditions for intubation can be achieved with pancuronium bromide alone or following suxamethonium. 2. pancuronium bromide is also indicated to promote mechanical ventilation by reducing or eliminating spontaneous breathing effort in intensive care patients.
diprivan 1% w/v emulsion for injection or infusion, pre filled syringe
astrazeneca uk limited - propofol 10 mg/ml - emulsion for infusion or injection